Biliary Cancer
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)(D7025C00001)
- Details
ClinicalTrials.gov ID:
NCT06109779
Diagnosis Type:
NA
USOR Number:
- Address
,
P: